Search
for

    Sort by

    Research 181–210 of 1000+

    1. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations
    2. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome Gynecological Endocrinology · 1997 · 38 citations
    3. Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women JAMA Network Open · 2024 · 37 citations
    4. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome Gynecological Endocrinology · 2008 · 37 citations
    5. Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran Hormone Research in Paediatrics · 2004 · 37 citations
    6. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021 · 36 citations
    7. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review Journal of Obstetrics and Gynaecology Research · 2017 · 36 citations
    8. Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging European Radiology · 2009 · 36 citations
    9. Polycystic ovary syndrome and its management: In view of oxidative stress BioMolecular Concepts · 2024 · 35 citations
    10. Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome BMC Medical Genomics · 2021 · 35 citations
    11. Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome Journal of Affective Disorders · 2015 · 35 citations
    12. PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME Arquivos De Gastroenterologia · 2015 · 35 citations
    13. Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome Experimental and Clinical Endocrinology & Diabetes · 2012 · 35 citations
    14. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clinical Endocrinology · 2011 · 35 citations
    15. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome International Journal of Gynecology & Obstetrics · 2008 · 35 citations
    16. Adolescent Polycystic Ovary Syndrome Annals of the New York Academy of Sciences · 1997 · 35 citations
    17. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome Fertility and Sterility · 2016 · 34 citations
    18. The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism · 2018 · 33 citations
    19. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome Reproductive Biology and Endocrinology · 2014 · 33 citations
    20. What every physician should know about polycystic ovary syndrome Dermatologic therapy · 2008 · 33 citations
    21. Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review Frontiers in Endocrinology · 2019 · 32 citations
    22. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure Human Reproduction · 2017 · 32 citations
    23. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype Journal of Obstetrics and Gynaecology Research · 2016 · 32 citations
    24. Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome Endocrine Practice · 2001 · 32 citations
    25. Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers Middle East Fertility Society Journal · 2023 · 31 citations
    26. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis Nutrients · 2021 · 31 citations
    27. Identifying genes associated with the development of human polycystic ovary syndrome Saudi Journal of Biological Sciences · 2020 · 31 citations
    28. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 31 citations
    29. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study Clinical Endocrinology · 2014 · 31 citations
    30. Polycystic Ovary Syndrome CRC Press eBooks · 2005 · 31 citations